<?xml version="1.0" encoding="UTF-8"?>
<xocs:doc content-type="Abstract" dbname="scopusbase" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd xocs-ani515.xsd" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><xocs:meta>
    <xocs:eid>2-s2.0-85178336140</xocs:eid>
    <xocs:oeid/>
    <xocs:doi>10.1016/j.pdpdt.2023.103897</xocs:doi>
    <xocs:pmid>37984525</xocs:pmid>
    <xocs:online-status>available</xocs:online-status>
    <xocs:pui>2028712850</xocs:pui>
    <xocs:pii>S1572100023006245</xocs:pii>
    <xocs:fulltext-eid score="81">1-s2.0-S1572100023006245</xocs:fulltext-eid>
    <xocs:sdfullavail>1</xocs:sdfullavail>
    <xocs:issn>15721000</xocs:issn>
    <xocs:volume>45</xocs:volume>
    <xocs:issue/>
    <xocs:author-surname>Christie</xocs:author-surname>
    <xocs:author-fi>C</xocs:author-fi>
    <xocs:firstpage/>
    <xocs:lastpage/>
    <xocs:sort-year>2024</xocs:sort-year>
    <xocs:sort-yyyymm>202402</xocs:sort-yyyymm>
    <xocs:pub-year>2024</xocs:pub-year>
    <xocs:timestamp yyyymmdd="20240109">2024-01-09T23:08:26.887008Z</xocs:timestamp>
    <xocs:orig-load-date yyyymmdd="20231209">2023-12-09</xocs:orig-load-date>
    <xocs:datesort>20240201</xocs:datesort>
    <xocs:indexeddate epoch="1702145178">2023-12-09T18:06:18.540486Z</xocs:indexeddate>
    <xocs:absavail>1</xocs:absavail>
    <xocs:suppressdummy>no</xocs:suppressdummy>
    <xocs:srctype>j</xocs:srctype>
    <xocs:subjareas><xocs:subjarea>BIOC</xocs:subjarea><xocs:subjarea>MEDI</xocs:subjarea></xocs:subjareas>
    <xocs:srctitle>Photodiagnosis and Photodynamic Therapy</xocs:srctitle>
    <xocs:countries><xocs:country>United States</xocs:country><xocs:country>Norway</xocs:country></xocs:countries>
    <xocs:languages><xocs:language>English</xocs:language></xocs:languages>
    <xocs:prefnameauids><xocs:prefnameauid>Christie, C.#7005704879</xocs:prefnameauid><xocs:prefnameauid>Hirschberg, H.#7005248934</xocs:prefnameauid><xocs:prefnameauid>Madsen, S.J.#7201510676</xocs:prefnameauid><xocs:prefnameauid>Peng, Q.#7202852317</xocs:prefnameauid></xocs:prefnameauids>
    <xocs:open-access><xocs:oa-access-effective-date>2023-12-13</xocs:oa-access-effective-date><xocs:oa-article-status is-open-access="1">Full</xocs:oa-article-status><xocs:oa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:oa-user-license><xocs:upw-open-access><xocs:upw-oa-article-status>false</xocs:upw-oa-article-status><xocs:upw-timestamp>2024-01-05T00:44:28.000055Z</xocs:upw-timestamp><xocs:upw-oa-journal-is-oa>false</xocs:upw-oa-journal-is-oa><xocs:upw-oa-journal-is-in-doaj>false</xocs:upw-oa-journal-is-in-doaj></xocs:upw-open-access></xocs:open-access>
    <xocs:funding-list has-funding-info="1" pui-match="primary"><xocs:funding-addon-generated-timestamp>2024-01-03T10:25:21.303Z</xocs:funding-addon-generated-timestamp><xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined</xocs:funding-addon-type><xocs:funding><xocs:funding-agency-matched-string>Norwegian Radium Hospital</xocs:funding-agency-matched-string><xocs:funding-id>SE 1305</xocs:funding-id></xocs:funding><xocs:funding-text>The authors are grateful for the support from the Norwegian Radium Hospital Research Grant nr SE 1305</xocs:funding-text></xocs:funding-list>
    <cto:doctype>ar</cto:doctype>
    <cto:group-id>85178336140</cto:group-id>
    <cto:ref-id>78651322039</cto:ref-id>
    <cto:ref-id>79952614272</cto:ref-id>
    <cto:ref-id>84871799914</cto:ref-id>
    <cto:ref-id>85140754068</cto:ref-id>
    <cto:ref-id>85164821906</cto:ref-id>
    <cto:ref-id>85079073265</cto:ref-id>
    <cto:ref-id>0034093158</cto:ref-id>
    <cto:ref-id>0029781336</cto:ref-id>
    <cto:ref-id>85178358243</cto:ref-id>
    <cto:ref-id>40649092768</cto:ref-id>
    <cto:ref-id>38049131877</cto:ref-id>
    <cto:ref-id>80052642756</cto:ref-id>
    <cto:ref-id>84986004219</cto:ref-id>
    <cto:ref-id>85048868596</cto:ref-id>
    <cto:ref-id>85056936002</cto:ref-id>
    <cto:ref-id>85038849652</cto:ref-id>
    <cto:ref-id>85063493635</cto:ref-id>
    <cto:ref-id>33751572020</cto:ref-id>
    <cto:ref-id>0025854108</cto:ref-id>
    <cto:ref-id>84938397658</cto:ref-id>
    <cto:ref-id>84960098496</cto:ref-id>
    <cto:ref-id>85012940270</cto:ref-id>
    <cto:ref-id>53249113443</cto:ref-id>
    <cto:ref-id>84884906073</cto:ref-id>
    <cto:ref-id>0028361447</cto:ref-id>
    <cto:ref-id>0037723119</cto:ref-id>
    <cto:ref-id>85028314999</cto:ref-id>
    <cto:ref-id>0035662672</cto:ref-id>
    <cto:ref-id>0032982493</cto:ref-id>
    <cto:ref-id>52949115237</cto:ref-id>
    <cto:ref-id>85082664741</cto:ref-id>
    <cto:unique-author seq="1"><cto:auth-initials>C.</cto:auth-initials><cto:auth-indexed-name>Christie C.</cto:auth-indexed-name><cto:auth-surname>Christie</cto:auth-surname><cto:auth-id>7005704879</cto:auth-id></cto:unique-author>
    <cto:unique-author seq="2"><cto:auth-initials>S.J.</cto:auth-initials><cto:auth-indexed-name>Madsen S.J.</cto:auth-indexed-name><cto:auth-surname>Madsen</cto:auth-surname><cto:auth-id>7201510676</cto:auth-id></cto:unique-author>
    <cto:unique-author seq="3"><cto:auth-initials>Q.</cto:auth-initials><cto:auth-indexed-name>Peng Q.</cto:auth-indexed-name><cto:auth-surname>Peng</cto:auth-surname><cto:auth-id>7202852317</cto:auth-id></cto:unique-author>
    <cto:unique-author seq="4"><cto:auth-initials>H.</cto:auth-initials><cto:auth-indexed-name>Hirschberg H.</cto:auth-indexed-name><cto:auth-surname>Hirschberg</cto:auth-surname><cto:auth-id>7005248934</cto:auth-id><cto:auth-e-address type="email">hhirschb@uci.edu</cto:auth-e-address></cto:unique-author>
    <cto:unique-auth-count>4</cto:unique-auth-count>
  </xocs:meta><xocs:item><item><ait:process-info><ait:date-delivered day="04" month="01" timestamp="2024-01-04T12:53:30.000030-05:00" year="2024"/><ait:date-sort day="01" month="02" year="2024"/><ait:status stage="S300" state="update" type="core"/></ait:process-info><bibrecord><item-info><copyright type="Elsevier">Copyright 2024 Elsevier B.V., All rights reserved.</copyright><itemidlist><ce:pii>S1572100023006245</ce:pii><ce:doi>10.1016/j.pdpdt.2023.103897</ce:doi><ce:ern>pii:S1572100023006245</ce:ern><itemid idtype="PUI">2028712850</itemid><itemid idtype="associatedPUI">642817005</itemid><itemid idtype="CAR-ID">952395929</itemid><itemid idtype="EMBASE">20231111880</itemid><itemid idtype="MEDL">37984525</itemid><itemid idtype="NURSNG">2023495497</itemid><itemid idtype="REAXYSCAR">20233602373</itemid><itemid idtype="RMC">2023505582</itemid><itemid idtype="SCOPUS">20234534939</itemid><itemid idtype="SCP">85178336140</itemid><itemid idtype="SGR">85178336140</itemid></itemidlist><history><date-created day="02" month="01" timestamp="BST 22:36:14" year="2024"/></history><dbcollection>EMBASE</dbcollection><dbcollection>MEDL</dbcollection><dbcollection>NURSNG</dbcollection><dbcollection>REAXYSCAR</dbcollection><dbcollection>RMC</dbcollection><dbcollection>SCOPUS</dbcollection><dbcollection>Scopusbase</dbcollection><external-source>Publisher</external-source></item-info><head><citation-info><citation-type code="ar"/><citation-language xml:lang="eng" language="English"/><abstract-language xml:lang="eng" language="English"/><author-keywords><author-keyword original="y" xml:lang="eng">Blood brain barrier</author-keyword><author-keyword original="y" xml:lang="eng">Macrophage delivery</author-keyword><author-keyword original="y" xml:lang="eng">Photodynamic therapy</author-keyword><author-keyword original="y" xml:lang="eng">Photosensitizer</author-keyword></author-keywords></citation-info><citation-title><titletext original="y" xml:lang="eng" language="English">Macrophages as a photosensitizer delivery system for photodynamic therapy: Potential for the local treatment of resected glioblastoma</titletext></citation-title><author-group><author auid="7005704879" author-instance-id="OB2BibRecID-952395929-b5e131d562b82695e97a2c73eac2df05-1" seq="1" type="auth"><ce:initials>C.</ce:initials><ce:indexed-name>Christie C.</ce:indexed-name><ce:surname>Christie</ce:surname><ce:given-name>Catherine</ce:given-name><preferred-name><ce:initials>C.</ce:initials><ce:indexed-name>Christie C.</ce:indexed-name><ce:surname>Christie</ce:surname><ce:given-name>Catherine</ce:given-name></preferred-name></author><author auid="7005248934" author-instance-id="OB2BibRecID-952395929-51a793843b55b5b449c7c58f4b0f8e89-1" seq="4" type="auth"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname><ce:given-name>Henry</ce:given-name><preferred-name><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname><ce:given-name>Henry</ce:given-name></preferred-name><ce:e-address type="email">hhirschb@uci.edu</ce:e-address></author><affiliation affiliation-instance-id="OB2BibRecID-952395929-5bdaab5db93176972d12f357e8716a53-1" afid="60010861" country="usa"><organization>Beckman Laser Institute</organization><organization>University of California</organization><city>Irvine</city><state>CA</state><postal-code>92617</postal-code><ce:source-text>aBeckman Laser Institute, University of California, Irvine, CA 92617, USA</ce:source-text><affiliation-id afid="60010861"/><affiliation-id afid="60007278"/><country>United States</country></affiliation></author-group><author-group><author auid="7201510676" author-instance-id="OB2BibRecID-952395929-fd45f59f40e140e763c10086220e9923-1" seq="2" type="auth"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname><ce:given-name>Steen J</ce:given-name><preferred-name><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname><ce:given-name>Steen J.</ce:given-name></preferred-name></author><author auid="7005248934" author-instance-id="OB2BibRecID-952395929-51a793843b55b5b449c7c58f4b0f8e89-1" seq="4" type="auth"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname><ce:given-name>Henry</ce:given-name><preferred-name><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname><ce:given-name>Henry</ce:given-name></preferred-name><ce:e-address type="email">hhirschb@uci.edu</ce:e-address></author><affiliation affiliation-instance-id="OB2BibRecID-952395929-0c6bc6dd557c40260222cdfda514dfc3-1" afid="60031892" country="usa" dptid="106906003"><organization>Department of Health Physics &amp; Diagnostic Sciences</organization><organization>University of Nevada</organization><city>Las Vegas</city><state>NV</state><postal-code>89154</postal-code><ce:source-text>bDepartment of Health Physics &amp; Diagnostic Sciences, University of Nevada, Las Vegas, NV 89154, USA</ce:source-text><affiliation-id afid="60031892" dptid="106906003"/><country>United States</country></affiliation></author-group><author-group><author auid="7202852317" author-instance-id="OB2BibRecID-952395929-4edb8759f7e6953414651882ae007ef2-1" seq="3" type="auth"><ce:initials>Q.</ce:initials><ce:indexed-name>Peng Q.</ce:indexed-name><ce:surname>Peng</ce:surname><ce:given-name>Qian</ce:given-name><preferred-name><ce:initials>Q.</ce:initials><ce:indexed-name>Peng Q.</ce:indexed-name><ce:surname>Peng</ce:surname><ce:given-name>Qian</ce:given-name></preferred-name></author><affiliation affiliation-instance-id="OB2BibRecID-952395929-955e725a09550b3d6381950a45c4304b-1" afid="60026108" country="nor" dptid="104326590"><organization>Pathology Clinic</organization><organization>4Department of Radiation Biology</organization><organization>Rikshospitalet-Radiumhospitalet HF Medical Center</organization><organization>University of Oslo</organization><city>Oslo</city><ce:source-text>cPathology Clinic, 4Department of Radiation Biology, Rikshospitalet-Radiumhospitalet HF Medical Center, University of Oslo, Oslo, Norway</ce:source-text><affiliation-id afid="60026108" dptid="104326590"/><affiliation-id afid="60010348"/><country>Norway</country></affiliation></author-group><correspondence><person author-instance-id="OB2BibRecID-952395929-1141e3f474e3d790055e8c1582fc2f15-1"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname><ce:given-name>Henry</ce:given-name></person><affiliation affiliation-instance-id="OB2BibRecID-952395929-81602e7f829b3e9b6bfbcc9e51c907e1-1" country="usa"><organization>Beckman Laser Institute</organization><organization>University of California</organization><city>Irvine</city><state>CA</state><postal-code>92617</postal-code><country>United States</country></affiliation><ce:e-address type="email">hhirschb@uci.edu</ce:e-address></correspondence><grantlist complete="y"><grant-text xml:lang="eng">The authors are grateful for the support from the Norwegian Radium Hospital Research Grant nr SE 1305</grant-text></grantlist><abstracts><abstract original="y" xml:lang="eng"><publishercopyright>© 2023</publishercopyright><ce:para>Background: Photodynamic therapy (PDT) efficacy is determined in part by the concentration of photosensitizer (PS) at the treatment site. The blood-brain barrier (BBB) poses a significant limitation on the transport of PS into the post-operative resection region where brain tumors most often recur. Macrophages (Ma), as opposed to free or nanoparticle bound agents, are known to actively migrate to and around tumors, and can therefore be used as delivery vectors for both drugs and photosensitizers. Methods: Mouse Ma (RAW264.7) and F98 rat glioma cells were used in all experiments along with the photosensitizer AlPcS<inf>2a</inf>. Mitomycin-treated Ma were loaded with photosensitizer (PS) and mixed with glioma cells, forming hybrid spheroids. F98 spheroids were incubated with supernatants derived from PS-loaded Ma (Ma<sup>PS</sup>). Light treatment (PDT) was administered at various radiant exposures from a 670 nm diode laser. The growth of both types of spheroids was evaluated by measurement of spheroid volume after 14 days in culture. Results: PDT on F98 cell spheroid cultures, mediated by either free or PS-released from Ma, demonstrated a significant growth inhibition with supernatants harvested after 4 and 24 h. A significant PDT-induced growth inhibition was demonstrated in the Ma<sup>PS</sup>/F98 hybrid spheroid experiments. Conclusion: Since the efficacy of PDT, mediated by either free or released photosensitizer was comparable, the uptake and released photosensitizer was not degraded. Ma<sup>PS</sup>, incorporated in hybrid tumor spheroids also mediated effective PDT. These results indicate that Ma have potential as an effective vector for photosensitizer delivery to resected brain tumors.</ce:para></abstract></abstracts><source country="nld" srcid="130008" type="j"><sourcetitle>Photodiagnosis and Photodynamic Therapy</sourcetitle><sourcetitle-abbrev>Photodiagn. Photodyn. Ther.</sourcetitle-abbrev><translated-sourcetitle xml:lang="eng">Photodiagnosis and Photodynamic Therapy</translated-sourcetitle><issn type="electronic">18731597</issn><issn type="print">15721000</issn><volisspag><voliss volume="45"/></volisspag><article-number>103897</article-number><publicationyear first="2024"/><publicationdate><year>2024</year><month>02</month><day>01</day><date-text>February 2024</date-text></publicationdate><website><ce:e-address type="email">https://www.sciencedirect.com/science/journal/15721000</ce:e-address></website><publisher><publishername>Elsevier B.V.</publishername></publisher></source><enhancement><classificationgroup><classifications type="ASJC"><classification>1304</classification><classification>2730</classification><classification>2708</classification><classification>2736</classification></classifications><classifications type="SUBJABBR"><classification>BIOC</classification><classification>MEDI</classification></classifications></classificationgroup></enhancement></head><tail><bibliography refcount="31"><reference id="1" reference-instance-id="OB2BibRecID-952395929-3af49c0ac6de80c13a40d290495edac7-1"><ref-info><ref-title><ref-titletext>Radiographic patterns of relapse in glioblastoma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0001</itemid><itemid idtype="SGR">78651322039</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.C.</ce:initials><ce:indexed-name>Chamberlain M.C.</ce:indexed-name><ce:surname>Chamberlain</ce:surname></author></ref-authors><ref-sourcetitle>J. Neurooncol.</ref-sourcetitle><ref-publicationyear first="2011"/><ref-volisspag><voliss volume="101"/><pagerange first="319" last="323"/></ref-volisspag></ref-info><ref-fulltext>Chamberlain, M.C., Radiographic patterns of relapse in glioblastoma. J. Neurooncol. 101 (2011), 319–323.</ref-fulltext><ce:source-text>Chamberlain M.C. (2011) Radiographic patterns of relapse in glioblastoma. J. Neurooncol. 101:319–23.</ce:source-text></reference><reference id="2" reference-instance-id="OB2BibRecID-952395929-ab0533f3eb7e3c3f316bed1284eb30b7-2"><ref-info><ref-title><ref-titletext>Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0002</itemid><itemid idtype="SGR">79952614272</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.C.</ce:initials><ce:indexed-name>Dobelbower M.C.</ce:indexed-name><ce:surname>Dobelbower</ce:surname></author><author seq="2"><ce:initials>O.L.</ce:initials><ce:indexed-name>Burnett O.L.</ce:indexed-name><ce:surname>Burnett</ce:surname><ce:suffix>III</ce:suffix></author><author seq="3"><ce:initials>R.A.</ce:initials><ce:indexed-name>Nordal R.A.</ce:indexed-name><ce:surname>Nordal</ce:surname></author><author seq="4"><ce:initials>L.B.</ce:initials><ce:indexed-name>Nabors L.B.</ce:indexed-name><ce:surname>Nabors</ce:surname></author><author seq="5"><ce:initials>J.M.</ce:initials><ce:indexed-name>Markert J.M.</ce:indexed-name><ce:surname>Markert</ce:surname></author><author seq="6"><ce:initials>M.D.</ce:initials><ce:indexed-name>Hyatt M.D.</ce:indexed-name><ce:surname>Hyatt</ce:surname></author><author seq="7"><ce:initials>J.B.</ce:initials><ce:indexed-name>Fiveash J.B.</ce:indexed-name><ce:surname>Fiveash</ce:surname></author></ref-authors><ref-sourcetitle>J. Med. Imaging Radiat. Oncol.</ref-sourcetitle><ref-publicationyear first="2011"/><ref-volisspag><voliss volume="55"/><pagerange first="77" last="81"/></ref-volisspag></ref-info><ref-fulltext>Dobelbower, M.C., Burnett, O.L. III, Nordal, R.A., Nabors, L.B., Markert, J.M., Hyatt, M.D., Fiveash, J.B., Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. J. Med. Imaging Radiat. Oncol. 55 (2011), 77–81.</ref-fulltext><ce:source-text>Dobelbower M.C., Burnett III O.L., Nordal R.A., Nabors L.B., Markert J.M., Hyatt M.D., Fiveash J.B. (2011) Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. J. Med. Imaging Radiat. Oncol. 55:77–81.</ce:source-text></reference><reference id="3" reference-instance-id="OB2BibRecID-952395929-40100e9cb4501f6df5c9d9d5ce518ebc-3"><ref-info><ref-title><ref-titletext>Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with Glioblastoma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0003</itemid><itemid idtype="SGR">84871799914</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>K.</ce:initials><ce:indexed-name>Petrecca K.</ce:indexed-name><ce:surname>Petrecca</ce:surname></author><author seq="2"><ce:initials>M.C.</ce:initials><ce:indexed-name>Guiot M.C.</ce:indexed-name><ce:surname>Guiot</ce:surname></author><author seq="3"><ce:initials>V.</ce:initials><ce:indexed-name>Panet-Raymond V.</ce:indexed-name><ce:surname>Panet-Raymond</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>J. Neurooncol.</ref-sourcetitle><ref-publicationyear first="2013"/><ref-volisspag><voliss volume="111"/><pagerange first="19" last="23"/></ref-volisspag></ref-info><ref-fulltext>Petrecca, K., Guiot, M.C., Panet-Raymond, V., et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with Glioblastoma. J. Neurooncol. 111 (2013), 19–23.</ref-fulltext><ce:source-text>Petrecca K., Guiot M.C., Panet-Raymond V. et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with Glioblastoma. J. Neurooncol. 111, 19–23 (2013).</ce:source-text></reference><reference id="4" reference-instance-id="OB2BibRecID-952395929-5d0a081e2d74a46bc3139d331048dbe0-4"><ref-info><ref-title><ref-titletext>The use of photodynamic therapy in the treatment of brain tumors—a review of the literature</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0004</itemid><itemid idtype="SGR">85140754068</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>D.</ce:initials><ce:indexed-name>Bartusik-Aebisher D.</ce:indexed-name><ce:surname>Bartusik-Aebisher</ce:surname></author><author seq="2"><ce:initials>A.</ce:initials><ce:indexed-name>Zolyniak A.</ce:indexed-name><ce:surname>Zołyniak</ce:surname></author><author seq="3"><ce:initials>E.</ce:initials><ce:indexed-name>Barnas E.</ce:indexed-name><ce:surname>Barna´s</ce:surname></author><author seq="4"><ce:initials>A.</ce:initials><ce:indexed-name>Machorowska-  Pieni azek A.</ce:indexed-name><ce:surname>Machorowska- ˙ Pieni ˛azek</ce:surname></author><author seq="5"><ce:initials>P.</ce:initials><ce:indexed-name>Oles P.</ce:indexed-name><ce:surname>Ole´s</ce:surname></author><author seq="6"><ce:initials>A.</ce:initials><ce:indexed-name>Kawczyk-Krupka A.</ce:indexed-name><ce:surname>Kawczyk-Krupka</ce:surname></author><author seq="7"><ce:initials>D.</ce:initials><ce:indexed-name>Aebisher D.</ce:indexed-name><ce:surname>Aebisher</ce:surname></author></ref-authors><ref-sourcetitle>Molecules</ref-sourcetitle><ref-publicationyear first="2022"/><ref-volisspag><voliss volume="27"/><pagerange first="6847"/></ref-volisspag></ref-info><ref-fulltext>Bartusik-Aebisher, D., Zołyniak, A., Barna´s, E., Machorowska- ˙ Pieni ˛azek, A., Ole´s, P., Kawczyk-Krupka, A., Aebisher, D., The use of photodynamic therapy in the treatment of brain tumors—a review of the literature. Molecules, 27, 2022, 6847.</ref-fulltext><ce:source-text>Bartusik-Aebisher, D.; Zołyniak, A.; Barna´s, E.; Machorowska- ˙ Pieni ˛azek, A.; Ole´s, P.; Kawczyk-Krupka, A.; Aebisher, D. The use of photodynamic therapy in the treatment of brain tumors—a review of the literature. Molecules 2022, 27, 6847.</ce:source-text></reference><reference id="5" reference-instance-id="OB2BibRecID-952395929-0599e6c96f4e69cd85faf756d9cafb83-5"><ref-info><ref-title><ref-titletext>Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0005</itemid><itemid idtype="SGR">85164821906</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>D.</ce:initials><ce:indexed-name>Bhanja D.</ce:indexed-name><ce:surname>Bhanja</ce:surname></author><author seq="2"><ce:initials>H.</ce:initials><ce:indexed-name>Wilding H.</ce:indexed-name><ce:surname>Wilding</ce:surname></author><author seq="3"><ce:initials>A.</ce:initials><ce:indexed-name>Baroz A.</ce:indexed-name><ce:surname>Baroz</ce:surname></author><author seq="4"><ce:initials>M.</ce:initials><ce:indexed-name>Trifoi M.</ce:indexed-name><ce:surname>Trifoi</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Cancers (Basel)</ref-sourcetitle><ref-publicationyear first="2023"/><ref-volisspag><voliss volume="15"/><pagerange first="3427"/></ref-volisspag></ref-info><ref-fulltext>Bhanja, D., Wilding, H., Baroz, A., Trifoi, M., et al. Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability. Cancers (Basel), 15, 2023, 3427.</ref-fulltext><ce:source-text>Bhanja, D., Wilding, H. Baroz, A., Trifoi, M. et al. Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability. Cancers (Basel) 2023, 15, 3427.</ce:source-text></reference><reference id="6" reference-instance-id="OB2BibRecID-952395929-e4ddf139facc7957fb0f5be1ff28218e-6"><ref-info><ref-title><ref-titletext>Photodynamic therapy for the treatment of glioblastoma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0006</itemid><itemid idtype="SGR">85079073265</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.W.</ce:initials><ce:indexed-name>Cramer S.W.</ce:indexed-name><ce:surname>Cramer</ce:surname></author><author seq="2"><ce:initials>C.C.</ce:initials><ce:indexed-name>Chen C.C.</ce:indexed-name><ce:surname>Chen</ce:surname></author></ref-authors><ref-sourcetitle>Front Surg.</ref-sourcetitle><ref-publicationyear first="2020"/><ref-volisspag><voliss volume="6"/><pagerange first="81"/></ref-volisspag><ref-text>Jan 21</ref-text></ref-info><ref-fulltext>Cramer, S.W., Chen, C.C., Photodynamic therapy for the treatment of glioblastoma. Front Surg., 6, 2020, 81 Jan 21.</ref-fulltext><ce:source-text>Cramer S.W., Chen C.C. Photodynamic therapy for the treatment of glioblastoma. Front Surg. 2020 Jan 21;6:81</ce:source-text></reference><reference id="7" reference-instance-id="OB2BibRecID-952395929-1cebfc4d7f20d174dc5f57833f65d873-7"><ref-info><ref-title><ref-titletext>Flow cytometric characterization of tumor associated macrophages in experimental gliomas</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0007</itemid><itemid idtype="SGR">0034093158</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>B.</ce:initials><ce:indexed-name>Badie B.</ce:indexed-name><ce:surname>Badie</ce:surname></author><author seq="2"><ce:initials>J.M.</ce:initials><ce:indexed-name>Schartner J.M.</ce:indexed-name><ce:surname>Schartner</ce:surname></author></ref-authors><ref-sourcetitle>Neurosurgery</ref-sourcetitle><ref-publicationyear first="2000"/><ref-volisspag><voliss volume="46"/><pagerange first="957" last="961"/></ref-volisspag><ref-text>discussion 61-2</ref-text></ref-info><ref-fulltext>Badie, B., Schartner, J.M., Flow cytometric characterization of tumor associated macrophages in experimental gliomas. Neurosurgery 46 (2000), 957–961 discussion 61-2.</ref-fulltext><ce:source-text>Badie B., Schartner J.M. (2000) Flow cytometric characterization of tumor associated macrophages in experimental gliomas. Neurosurgery; 46:957–61 discussion 61-2.</ce:source-text></reference><reference id="8" reference-instance-id="OB2BibRecID-952395929-147f1d102b4a6654fc22a3963fe6aa90-8"><ref-info><ref-title><ref-titletext>Distribution and characterization of microglia/macrophages in human brain tumors</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0008</itemid><itemid idtype="SGR">0029781336</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>W.</ce:initials><ce:indexed-name>Roggendorf W.</ce:indexed-name><ce:surname>Roggendorf</ce:surname></author><author seq="2"><ce:initials>S.</ce:initials><ce:indexed-name>Strupp S.</ce:indexed-name><ce:surname>Strupp</ce:surname></author><author seq="3"><ce:initials>W.</ce:initials><ce:indexed-name>Paulus W.</ce:indexed-name><ce:surname>Paulus</ce:surname></author></ref-authors><ref-sourcetitle>Acta Neuropathol.</ref-sourcetitle><ref-publicationyear first="2004"/><ref-volisspag><voliss volume="92"/><pagerange first="288" last="293"/></ref-volisspag><ref-text>1996</ref-text></ref-info><ref-fulltext>Roggendorf, W., Strupp, S., Paulus, W., Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 92 (2004), 288–293 1996.</ref-fulltext><ce:source-text>Roggendorf W., Strupp S., Paulus W. (2004) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 1996; 92:288–93.</ce:source-text></reference><reference id="9" reference-instance-id="OB2BibRecID-952395929-ca9c8006095626f0d919df932741a0f1-9"><ref-info><refd-itemidlist><itemid idtype="FRAGMENTID">bib0009</itemid><itemid idtype="SGR">85178358243</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>A.</ce:initials><ce:indexed-name>Carolina A.</ce:indexed-name><ce:surname>Carolina</ce:surname></author><author seq="2"><ce:initials>C.</ce:initials><ce:indexed-name>Fonseca C.</ce:indexed-name><ce:surname>Fonseca</ce:surname></author><author seq="3"><ce:initials>B.</ce:initials><ce:indexed-name>Badie B.</ce:indexed-name><ce:surname>Badie</ce:surname></author></ref-authors><ref-publicationyear first="2013"/><ref-text>Microglia, macrophages in malignant gliomas: recent discoveries and implications for promising therapies clinical and developmental immunology volume.</ref-text></ref-info><ref-fulltext>Carolina A., Fonseca C., and Badie B. Microglia, macrophages in malignant gliomas: recent discoveries and implications for promising therapies clinical and developmental immunology volume 2013.</ref-fulltext><ce:source-text>Carolina A., Fonseca C., and Badie B. Microglia, macrophages in malignant gliomas: recent discoveries and implications for promising therapies clinical and developmental immunology volume 2013.</ce:source-text></reference><reference id="10" reference-instance-id="OB2BibRecID-952395929-804d3f205f3572c41e49cf7fefb5633b-10"><ref-info><ref-title><ref-titletext>In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0010</itemid><itemid idtype="SGR">40649092768</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.</ce:initials><ce:indexed-name>Valable S.</ce:indexed-name><ce:surname>Valable</ce:surname></author><author seq="2"><ce:initials>E.L.</ce:initials><ce:indexed-name>Barbier E.L.</ce:indexed-name><ce:surname>Barbier</ce:surname></author><author seq="3"><ce:initials>M.</ce:initials><ce:indexed-name>Bernaudin M.</ce:indexed-name><ce:surname>Bernaudin</ce:surname></author><author seq="4"><ce:initials>S.</ce:initials><ce:indexed-name>Roussel S.</ce:indexed-name><ce:surname>Roussel</ce:surname></author><author seq="5"><ce:initials>C.</ce:initials><ce:indexed-name>Segebarth C.</ce:indexed-name><ce:surname>Segebarth</ce:surname></author><author seq="6"><ce:initials>E.</ce:initials><ce:indexed-name>Petit E.</ce:indexed-name><ce:surname>Petit</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Neuroimage</ref-sourcetitle><ref-publicationyear first="2008"/><ref-volisspag><voliss issue="2" volume="40"/><pagerange first="973" last="983"/></ref-volisspag><ref-text>Apr 1</ref-text></ref-info><ref-fulltext>Valable, S., Barbier, E.L., Bernaudin, M., Roussel, S., Segebarth, C., Petit, E., et al. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 40:2 (2008), 973–983 Apr 1.</ref-fulltext><ce:source-text>Valable S., Barbier E.L., Bernaudin M., Roussel S., Segebarth C., Petit E., et al. (2008) In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage Apr 1;40(2):973–983.</ce:source-text></reference><reference id="11" reference-instance-id="OB2BibRecID-952395929-8707b758d1d43ca7bb356745f30ddeba-11"><ref-info><ref-title><ref-titletext>A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0011</itemid><itemid idtype="SGR">38049131877</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.R.</ce:initials><ce:indexed-name>Choi M.R.</ce:indexed-name><ce:surname>Choi</ce:surname></author><author seq="2"><ce:initials>K.J.</ce:initials><ce:indexed-name>Stanton-Maxey K.J.</ce:indexed-name><ce:surname>Stanton-Maxey</ce:surname></author><author seq="3"><ce:initials>J.K.</ce:initials><ce:indexed-name>Stanley J.K.</ce:indexed-name><ce:surname>Stanley</ce:surname></author><author seq="4"><ce:initials>C.S.</ce:initials><ce:indexed-name>Levin C.S.</ce:indexed-name><ce:surname>Levin</ce:surname></author><author seq="5"><ce:initials>R.</ce:initials><ce:indexed-name>Bardhan R.</ce:indexed-name><ce:surname>Bardhan</ce:surname></author><author seq="6"><ce:initials>D.</ce:initials><ce:indexed-name>Akin D.</ce:indexed-name><ce:surname>Akin</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Nano Lett.</ref-sourcetitle><ref-publicationyear first="2007"/><ref-volisspag><voliss issue="12" volume="7"/><pagerange first="3759" last="3765"/></ref-volisspag></ref-info><ref-fulltext>Choi, M.R., Stanton-Maxey, K.J., Stanley, J.K., Levin, C.S., Bardhan, R., Akin, D., et al. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7:12 (2007), 3759–3765.</ref-fulltext><ce:source-text>Choi M.R., Stanton-Maxey K.J., Stanley J.K., Levin C.S., Bardhan R., Akin D., et al. A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 2007;7(12):3759–3765.</ce:source-text></reference><reference id="12" reference-instance-id="OB2BibRecID-952395929-51c9c232b20fa841016b285f9448d104-12"><ref-info><ref-title><ref-titletext>Photothermal treatment of glioma: an in vitro study macrophage-mediated delivery of gold nanoshells</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0012</itemid><itemid idtype="SGR">80052642756</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.K.</ce:initials><ce:indexed-name>Baek S.K.</ce:indexed-name><ce:surname>Baek</ce:surname></author><author seq="2"><ce:initials>A.R.</ce:initials><ce:indexed-name>Makkouk A.R.</ce:indexed-name><ce:surname>Makkouk</ce:surname></author><author seq="3"><ce:initials>T.</ce:initials><ce:indexed-name>Krasieva T.</ce:indexed-name><ce:surname>Krasieva</ce:surname></author><author seq="4"><ce:initials>C.H.</ce:initials><ce:indexed-name>Sun C.H.</ce:indexed-name><ce:surname>Sun</ce:surname></author><author seq="5"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="6"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>J. Neurooncol.</ref-sourcetitle><ref-publicationyear first="2011"/><ref-volisspag><voliss issue="2" volume="104"/><pagerange first="439" last="448"/></ref-volisspag></ref-info><ref-fulltext>Baek, S.K., Makkouk, A.R., Krasieva, T., Sun, C.H., Madsen, S.J., Hirschberg, H., Photothermal treatment of glioma: an in vitro study macrophage-mediated delivery of gold nanoshells. J. Neurooncol. 104:2 (2011), 439–448.</ref-fulltext><ce:source-text>Baek S.K., Makkouk A.R., Krasieva T., Sun C.H., Madsen S.J., Hirschberg H. Photothermal treatment of glioma: an in vitro study macrophage-mediated delivery of gold nanoshells. J. Neurooncol. 104(2), 439–448 (2011).</ce:source-text></reference><reference id="13" reference-instance-id="OB2BibRecID-952395929-f4a197716874d1c342277c1ecac746a2-13"><ref-info><ref-title><ref-titletext>Nanomedicine engulfed by macrophages for targeted tumor therapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0013</itemid><itemid idtype="SGR">84986004219</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.</ce:initials><ce:indexed-name>Li S.</ce:indexed-name><ce:surname>Li</ce:surname></author><author seq="2"><ce:initials>S.</ce:initials><ce:indexed-name>Feng S.</ce:indexed-name><ce:surname>Feng</ce:surname></author><author seq="3"><ce:initials>L.</ce:initials><ce:indexed-name>Ding L.</ce:indexed-name><ce:surname>Ding</ce:surname></author><author seq="4"><ce:initials>Y.</ce:initials><ce:indexed-name>Liu Y.</ce:indexed-name><ce:surname>Liu</ce:surname></author><author seq="5"><ce:initials>Q.</ce:initials><ce:indexed-name>Zhu Q.</ce:indexed-name><ce:surname>Zhu</ce:surname></author><author seq="6"><ce:initials>Z.</ce:initials><ce:indexed-name>Qian Z.</ce:indexed-name><ce:surname>Qian</ce:surname></author><author seq="7"><ce:initials>Y.</ce:initials><ce:indexed-name>Gu Y.</ce:indexed-name><ce:surname>Gu</ce:surname></author></ref-authors><ref-sourcetitle>Int. J. Nanomed.</ref-sourcetitle><ref-publicationyear first="2016"/><ref-volisspag><voliss volume="11"/><pagerange first="4107" last="4124"/></ref-volisspag><ref-text>Aug 23</ref-text></ref-info><ref-fulltext>Li, S., Feng, S., Ding, L., Liu, Y., Zhu, Q., Qian, Z., Gu, Y.1., Nanomedicine engulfed by macrophages for targeted tumor therapy. Int. J. Nanomed. 11 (2016), 4107–4124 Aug 23.</ref-fulltext><ce:source-text>Li S., Feng S., Ding L., Liu Y., Zhu Q., Qian Z., Gu Y.1. Nanomedicine engulfed by macrophages for targeted tumor therapy. Int. J. Nanomed. 2016 Aug 23;11:4107–24</ce:source-text></reference><reference id="14" reference-instance-id="OB2BibRecID-952395929-aa26ce103ba87e39e40941eddaa2e7a5-14"><ref-info><ref-title><ref-titletext>Monocyte-mediated chemotherapy drug delivery in glioblastoma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0014</itemid><itemid idtype="SGR">85048868596</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>C.</ce:initials><ce:indexed-name>Wang C.</ce:indexed-name><ce:surname>Wang</ce:surname></author><author seq="2"><ce:initials>K.</ce:initials><ce:indexed-name>Li K.</ce:indexed-name><ce:surname>Li</ce:surname></author><author seq="3"><ce:initials>T.</ce:initials><ce:indexed-name>Li T.</ce:indexed-name><ce:surname>Li</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Nanomedicine (Lond)</ref-sourcetitle><ref-publicationyear first="2018"/><ref-volisspag><voliss volume="13"/><pagerange first="157" last="178"/></ref-volisspag></ref-info><ref-fulltext>Wang, C., Li, K., Li, T., et al. Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine (Lond) 13 (2018), 157–178.</ref-fulltext><ce:source-text>Wang C., Li K., Li T., et al. (2018). Monocyte-mediated chemotherapy drug delivery in glioblastoma. Nanomedicine (Lond) 13:157–78.</ce:source-text></reference><reference id="15" reference-instance-id="OB2BibRecID-952395929-85084a8d4ccefe2819ca6a323e8f866e-15"><ref-info><ref-title><ref-titletext>Primary M1 macrophages as multi-functional carrier combined with PLGA nanoparticle delivering anti-cancer drug for efficient glioma therapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0015</itemid><itemid idtype="SGR">85056936002</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>L.</ce:initials><ce:indexed-name>Pang L.</ce:indexed-name><ce:surname>Pang</ce:surname></author><author seq="2"><ce:initials>Y.</ce:initials><ce:indexed-name>Zhu Y.</ce:indexed-name><ce:surname>Zhu</ce:surname></author><author seq="3"><ce:initials>J.</ce:initials><ce:indexed-name>Qin J.</ce:indexed-name><ce:surname>Qin</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Drug Deliv.</ref-sourcetitle><ref-publicationyear first="2018"/><ref-volisspag><voliss volume="25"/><pagerange first="1922" last="1931"/></ref-volisspag></ref-info><ref-fulltext>Pang, L., Zhu, Y., Qin, J., et al. Primary M1 macrophages as multi-functional carrier combined with PLGA nanoparticle delivering anti-cancer drug for efficient glioma therapy. Drug Deliv. 25 (2018), 1922–1931.</ref-fulltext><ce:source-text>Pang L., Zhu Y., Qin J., et al. (2018). Primary M1 macrophages as multi-functional carrier combined with PLGA nanoparticle delivering anti-cancer drug for efficient glioma therapy. Drug Deliv. 25:1922–31.</ce:source-text></reference><reference id="16" reference-instance-id="OB2BibRecID-952395929-5f7b7a90fa763dd842a5f6fcb11abf50-16"><ref-info><ref-title><ref-titletext>Photochemical internalization enhanced macrophage delivered chemotherapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0016</itemid><itemid idtype="SGR">85038849652</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>D.</ce:initials><ce:indexed-name>Shin D.</ce:indexed-name><ce:surname>Shin</ce:surname></author><author seq="2"><ce:initials>C.</ce:initials><ce:indexed-name>Christie C.</ce:indexed-name><ce:surname>Christie</ce:surname></author><author seq="3"><ce:initials>D.</ce:initials><ce:indexed-name>Ju D.</ce:indexed-name><ce:surname>Ju</ce:surname></author><author seq="4"><ce:initials>R.K.</ce:initials><ce:indexed-name>Nair R.K.</ce:indexed-name><ce:surname>Nair</ce:surname></author><author seq="5"><ce:initials>S.</ce:initials><ce:indexed-name>Molina S.</ce:indexed-name><ce:surname>Molina</ce:surname></author><author seq="6"><ce:initials>K.</ce:initials><ce:indexed-name>Berg K.</ce:indexed-name><ce:surname>Berg</ce:surname></author><author seq="7"><ce:initials>T.B.</ce:initials><ce:indexed-name>Krasieva T.B.</ce:indexed-name><ce:surname>Krasieva</ce:surname></author><author seq="8"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="9"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>Photodiagn. Photodyn. Ther.</ref-sourcetitle><ref-publicationyear first="2018"/><ref-volisspag><voliss volume="21"/><pagerange first="156" last="162"/></ref-volisspag></ref-info><ref-fulltext>Shin, D., Christie, C., Ju, D., Nair, R.K., Molina, S., Berg, K., Krasieva, T.B., Madsen, S.J., Hirschberg, H., Photochemical internalization enhanced macrophage delivered chemotherapy. Photodiagn. Photodyn. Ther. 21 (2018), 156–162.</ref-fulltext><ce:source-text>Shin D., Christie C., Ju D., Nair R.K., Molina S., Berg K., Krasieva T.B., Madsen S.J., Hirschberg H. (2018) Photochemical internalization enhanced macrophage delivered chemotherapy. Photodiagn. Photodyn. Ther. 21:156–62.</ce:source-text></reference><reference id="17" reference-instance-id="OB2BibRecID-952395929-a1669befe8c4c8d1c72739594c2d1404-17"><ref-info><ref-title><ref-titletext>Macrophages as delivery vehicles for anticancer agents</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0017</itemid><itemid idtype="SGR">85063493635</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="2"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>Ther. Deliv.</ref-sourcetitle><ref-publicationyear first="2019"/><ref-volisspag><voliss issue="3" volume="10"/><pagerange first="189" last="201"/></ref-volisspag><ref-text>Mar</ref-text></ref-info><ref-fulltext>Madsen, S.J., Hirschberg, H., Macrophages as delivery vehicles for anticancer agents. Ther. Deliv. 10:3 (2019), 189–201 Mar.</ref-fulltext><ce:source-text>Madsen S.J., Hirschberg H. Macrophages as delivery vehicles for anticancer agents. Ther. Deliv. 2019 Mar;10(3):189–201.</ce:source-text></reference><reference id="18" reference-instance-id="OB2BibRecID-952395929-59fea330425b511c29c8ab497cf85d80-18"><ref-info><ref-title><ref-titletext>Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0018</itemid><itemid idtype="SGR">33751572020</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>A.</ce:initials><ce:indexed-name>Ivascu A.</ce:indexed-name><ce:surname>Ivascu</ce:surname></author><author seq="2"><ce:initials>M.</ce:initials><ce:indexed-name>Kubbies M.</ce:indexed-name><ce:surname>Kubbies</ce:surname></author></ref-authors><ref-sourcetitle>Anal. J. Biomol. Screen</ref-sourcetitle><ref-publicationyear first="2006"/><ref-volisspag><voliss issue="8" volume="11"/><pagerange first="922" last="932"/></ref-volisspag></ref-info><ref-fulltext>Ivascu, A., Kubbies, M., Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity. Anal. J. Biomol. Screen 11:8 (2006), 922–932.</ref-fulltext><ce:source-text>Ivascu A., Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity Anal. J. Biomol. Screen 2006;11(8);922–932.</ce:source-text></reference><reference id="19" reference-instance-id="OB2BibRecID-952395929-e06642787c3726eb7097df68d176cd6f-19"><ref-info><ref-title><ref-titletext>Photofrin uptake by murine macrophages</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0019</itemid><itemid idtype="SGR">0025854108</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.</ce:initials><ce:indexed-name>Korbelik M.</ce:indexed-name><ce:surname>Korbelik</ce:surname></author><author seq="2"><ce:initials>G.</ce:initials><ce:indexed-name>Krosl G.</ce:indexed-name><ce:surname>Krosl</ce:surname></author><author seq="3"><ce:initials>D.J.</ce:initials><ce:indexed-name>Chaplin D.J.</ce:indexed-name><ce:surname>Chaplin</ce:surname></author></ref-authors><ref-sourcetitle>Cancer Res.</ref-sourcetitle><ref-publicationyear first="1991"/></ref-info><ref-fulltext>Korbelik, M., Krosl, G., Chaplin, D.J., Photofrin uptake by murine macrophages. Cancer Res., 1991.</ref-fulltext><ce:source-text>Korbelik M., Krosl G., Chaplin D.J. Photofrin uptake by murine macrophages. Cancer Res. 1991;</ce:source-text></reference><reference id="20" reference-instance-id="OB2BibRecID-952395929-c9c209ce04990815fdd315755ed05bf1-20"><ref-info><ref-title><ref-titletext>The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0020</itemid><itemid idtype="SGR">84938397658</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.</ce:initials><ce:indexed-name>Korbelik M.</ce:indexed-name><ce:surname>Korbelik</ce:surname></author><author seq="2"><ce:initials>M.R.</ce:initials><ce:indexed-name>Hamblin M.R.</ce:indexed-name><ce:surname>Hamblin</ce:surname></author></ref-authors><ref-sourcetitle>Photochem. Photobiol. Sci.</ref-sourcetitle><ref-publicationyear first="2015"/><ref-volisspag><voliss issue="8" volume="14"/><pagerange first="1403" last="1409"/></ref-volisspag><ref-text>August</ref-text></ref-info><ref-fulltext>Korbelik, M., Hamblin, M.R., The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy. Photochem. Photobiol. Sci. 14:8 (2015), 1403–1409 August.</ref-fulltext><ce:source-text>Korbelik M. and Hamblin M.R. The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy. Photochem. Photobiol. Sci. 2015 August; 14(8): 1403–1409</ce:source-text></reference><reference id="21" reference-instance-id="OB2BibRecID-952395929-588ea32cb0323aff9b30c19fee74f650-21"><ref-info><ref-title><ref-titletext>The brain tissue response to surgical injury and its possible contribution to glioma recurrence</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0021</itemid><itemid idtype="SGR">84960098496</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>L.</ce:initials><ce:indexed-name>Hamard L.</ce:indexed-name><ce:surname>Hamard</ce:surname></author><author seq="2"><ce:initials>D.</ce:initials><ce:indexed-name>Ratel D.</ce:indexed-name><ce:surname>Ratel</ce:surname></author><author seq="3"><ce:initials>L.</ce:initials><ce:indexed-name>Selek L.</ce:indexed-name><ce:surname>Selek</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>J. Neurooncol.</ref-sourcetitle><ref-publicationyear first="2016"/><ref-volisspag><voliss volume="128"/><pagerange first="1" last="8"/></ref-volisspag></ref-info><ref-fulltext>Hamard, L., Ratel, D., Selek, L., et al. The brain tissue response to surgical injury and its possible contribution to glioma recurrence. J. Neurooncol. 128 (2016), 1–8.</ref-fulltext><ce:source-text>Hamard L., Ratel D., Selek L. et al. The brain tissue response to surgical injury and its possible contribution to glioma recurrence. J. Neurooncol. (2016) 128:1–8</ce:source-text></reference><reference id="22" reference-instance-id="OB2BibRecID-952395929-f2354320dd7f97340b649284332bcc22-22"><ref-info><ref-title><ref-titletext>Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0022</itemid><itemid idtype="SGR">85012940270</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>H.</ce:initials><ce:indexed-name>Zhu H.</ce:indexed-name><ce:surname>Zhu</ce:surname></author><author seq="2"><ce:initials>L.</ce:initials><ce:indexed-name>Leiss L.</ce:indexed-name><ce:surname>Leiss</ce:surname></author><author seq="3"><ce:initials>N.</ce:initials><ce:indexed-name>Yang N.</ce:indexed-name><ce:surname>Yang</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Oncotarget</ref-sourcetitle><ref-publicationyear first="2017"/><ref-volisspag><voliss issue="7" volume="8"/><pagerange first="12145" last="12157"/></ref-volisspag></ref-info><ref-fulltext>Zhu, H., Leiss, L., Yang, N., et al. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy. Oncotarget 8:No. 7 (2017), 12145–12157.</ref-fulltext><ce:source-text>Zhu H., Leiss L., Yang N., et al. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy. Oncotarget, 2017, Vol. 8, (No. 7), pp: 12145–12157.</ce:source-text></reference><reference id="23" reference-instance-id="OB2BibRecID-952395929-ef9fb622f848aa59f956b66938417b05-23"><ref-info><ref-title><ref-titletext>Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0023</itemid><itemid idtype="SGR">53249113443</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author><author seq="2"><ce:initials>F.A.</ce:initials><ce:indexed-name>Uzal F.A.</ce:indexed-name><ce:surname>Uzal</ce:surname></author><author seq="3"><ce:initials>D.</ce:initials><ce:indexed-name>Chighvinadze D.</ce:indexed-name><ce:surname>Chighvinadze</ce:surname></author><author seq="4"><ce:initials>M.J.</ce:initials><ce:indexed-name>Zhang M.J.</ce:indexed-name><ce:surname>Zhang</ce:surname></author><author seq="5"><ce:initials>Q.</ce:initials><ce:indexed-name>Peng Q.</ce:indexed-name><ce:surname>Peng</ce:surname></author><author seq="6"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author></ref-authors><ref-sourcetitle>Lasers Surg. Med.</ref-sourcetitle><ref-publicationyear first="2008"/><ref-volisspag><voliss volume="40"/><pagerange first="535" last="542"/></ref-volisspag></ref-info><ref-fulltext>Hirschberg, H., Uzal, F.A., Chighvinadze, D., Zhang, M.J., Peng, Q., Madsen, S.J., Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg. Med. 40 (2008), 535–542.</ref-fulltext><ce:source-text>Hirschberg H., Uzal F.A., Chighvinadze D., Zhang M.J., Peng Q., Madsen S.J. Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg. Med. 2008; 40:535–42.</ce:source-text></reference><reference id="24" reference-instance-id="OB2BibRecID-952395929-870b09bb2a955214e1d76e46b443513a-24"><ref-info><ref-title><ref-titletext>Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0024</itemid><itemid idtype="SGR">84884906073</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="2"><ce:initials>H.M.</ce:initials><ce:indexed-name>Gach H.M.</ce:indexed-name><ce:surname>Gach</ce:surname></author><author seq="3"><ce:initials>S.J.</ce:initials><ce:indexed-name>Hong S.J.</ce:indexed-name><ce:surname>Hong</ce:surname></author><author seq="4"><ce:initials>F.A.</ce:initials><ce:indexed-name>Uzal F.A.</ce:indexed-name><ce:surname>Uzal</ce:surname></author><author seq="5"><ce:initials>Q.</ce:initials><ce:indexed-name>Peng Q.</ce:indexed-name><ce:surname>Peng</ce:surname></author><author seq="6"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>Lasers Surg. Med.</ref-sourcetitle><ref-publicationyear first="2013"/><ref-volisspag><voliss issue="8" volume="45"/><pagerange first="524" last="532"/></ref-volisspag></ref-info><ref-fulltext>Madsen, S.J., Gach, H.M., Hong, S.J., Uzal, F.A., Peng, Q., Hirschberg, H., Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption. Lasers Surg. Med. 45:8 (2013), 524–532.</ref-fulltext><ce:source-text>Madsen S.J., Gach H.M., Hong S.J., Uzal F.A., Peng Q., Hirschberg H. Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption. Lasers Surg. Med. 45(8), 524–32 (2013).</ce:source-text></reference><reference id="25" reference-instance-id="OB2BibRecID-952395929-f3672954c53a7a7c1be14381ad12cefb-25"><ref-info><ref-title><ref-titletext>Drug and radiation resistance in spheroids: cell contact and kinetics</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0025</itemid><itemid idtype="SGR">0028361447</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>P.L.</ce:initials><ce:indexed-name>Olive P.L.</ce:indexed-name><ce:surname>Olive</ce:surname></author><author seq="2"><ce:initials>R.E.</ce:initials><ce:indexed-name>Durand R.E.</ce:indexed-name><ce:surname>Durand</ce:surname></author></ref-authors><ref-sourcetitle>Cancer Metastasis Rev.</ref-sourcetitle><ref-publicationyear first="1994"/><ref-volisspag><voliss volume="13"/><pagerange first="121" last="138"/></ref-volisspag></ref-info><ref-fulltext>Olive, P.L., Durand, R.E., Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev. 13 (1994), 121–138.</ref-fulltext><ce:source-text>Olive P.L., Durand R.E. Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev. 1994;13:121–138.</ce:source-text></reference><reference id="26" reference-instance-id="OB2BibRecID-952395929-f203660c929956dfd6b5f8e406da99f6-26"><ref-info><ref-title><ref-titletext>Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0026</itemid><itemid idtype="SGR">0037723119</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="2"><ce:initials>C.H.</ce:initials><ce:indexed-name>Sun C.H.</ce:indexed-name><ce:surname>Sun</ce:surname></author><author seq="3"><ce:initials>B.J.</ce:initials><ce:indexed-name>Tromberg B.J.</ce:indexed-name><ce:surname>Tromberg</ce:surname></author><author seq="4"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>J. Neurooncol.</ref-sourcetitle><ref-publicationyear first="2003"/><ref-volisspag><voliss issue="3" volume="62"/><pagerange first="243" last="250"/></ref-volisspag><ref-text>May</ref-text></ref-info><ref-fulltext>Madsen, S.J., Sun, C.H., Tromberg, B.J., Hirschberg, H., Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J. Neurooncol. 62:3 (2003), 243–250 May.</ref-fulltext><ce:source-text>Madsen S.J., Sun C.H., Tromberg B.J., Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids J. Neurooncol. 2003 May;62(3):243–50</ce:source-text></reference><reference id="27" reference-instance-id="OB2BibRecID-952395929-6eaa293c28bf1636381fce868c2afa89-27"><ref-info><ref-title><ref-titletext>Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: possible mechanisms and approaches for overcoming PDT-resistance</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0027</itemid><itemid idtype="SGR">85028314999</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>C.E.</ce:initials><ce:indexed-name>Olsen C.E.</ce:indexed-name><ce:surname>Olsen</ce:surname></author><author seq="2"><ce:initials>A.</ce:initials><ce:indexed-name>Weyergang A.</ce:indexed-name><ce:surname>Weyergang</ce:surname></author><author seq="3"><ce:initials>V.T.</ce:initials><ce:indexed-name>Edwards V.T.</ce:indexed-name><ce:surname>Edwards</ce:surname></author><author seq="4"><ce:initials>K.</ce:initials><ce:indexed-name>Berg K.</ce:indexed-name><ce:surname>Berg</ce:surname></author><author seq="5"><ce:initials>A.</ce:initials><ce:indexed-name>Brech A.</ce:indexed-name><ce:surname>Brech</ce:surname></author><author seq="6"><ce:initials>S.</ce:initials><ce:indexed-name>Weisheit S.</ce:indexed-name><ce:surname>Weisheit</ce:surname></author><author seq="7"><ce:initials>A.</ce:initials><ce:indexed-name>Hogset A.</ce:indexed-name><ce:surname>Høgset</ce:surname></author><author seq="8"><ce:initials>P.K.</ce:initials><ce:indexed-name>Selbo P.K.</ce:indexed-name><ce:surname>Selbo</ce:surname></author></ref-authors><ref-sourcetitle>Biochem. Pharmacol.</ref-sourcetitle><ref-publicationyear first="2017"/><ref-volisspag><voliss volume="144"/><pagerange first="63" last="77"/></ref-volisspag><ref-text>Nov 15</ref-text></ref-info><ref-fulltext>Olsen, C.E., Weyergang, A., Edwards, V.T., Berg, K., Brech, A., Weisheit, S., Høgset, A., Selbo, P.K., Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: possible mechanisms and approaches for overcoming PDT-resistance. Biochem. Pharmacol. 144 (2017), 63–77 Nov 15.</ref-fulltext><ce:source-text>Olsen C.E., Weyergang A., Edwards V.T., Berg K., Brech A., Weisheit S., Høgset A., Selbo P.K. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: possible mechanisms and approaches for overcoming PDT-resistance Biochem. Pharmacol. 2017 Nov 15;144:63–77</ce:source-text></reference><reference id="28" reference-instance-id="OB2BibRecID-952395929-68e75eb283bb0d011ae6433a96f53df9-28"><ref-info><ref-title><ref-titletext>Development of a novel balloon applicator for optimizing light delivery in photodynamic therapy</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0028</itemid><itemid idtype="SGR">0035662672</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.J.</ce:initials><ce:indexed-name>Madsen S.J.</ce:indexed-name><ce:surname>Madsen</ce:surname></author><author seq="2"><ce:initials>C.H.</ce:initials><ce:indexed-name>Sun C.H.</ce:indexed-name><ce:surname>Sun</ce:surname></author><author seq="3"><ce:initials>B.</ce:initials><ce:indexed-name>Tromberg B.</ce:indexed-name><ce:surname>Tromberg</ce:surname></author><author seq="4"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>Lasers Surg. Med.</ref-sourcetitle><ref-publicationyear first="2001"/><ref-volisspag><voliss volume="29"/><pagerange first="406" last="412"/></ref-volisspag></ref-info><ref-fulltext>Madsen, S.J., Sun, C.H., Tromberg, B., Hirschberg, H., Development of a novel balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg. Med. 29 (2001), 406–412.</ref-fulltext><ce:source-text>Madsen S.J., Sun C.H., Tromberg B., and Hirschberg H. (2001) Development of a novel balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg. Med. 29:406–412</ce:source-text></reference><reference id="29" reference-instance-id="OB2BibRecID-952395929-76afeeb7436237a09258d1ef09cbbdce-29"><ref-info><ref-title><ref-titletext>Intracavity fractionated balloon brachytherapy in glioblastoma</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0029</itemid><itemid idtype="SGR">0032982493</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>T.B.</ce:initials><ce:indexed-name>Johannesen T.B.</ce:indexed-name><ce:surname>Johannesen</ce:surname></author><author seq="2"><ce:initials>K.</ce:initials><ce:indexed-name>Watne K.</ce:indexed-name><ce:surname>Watne</ce:surname></author><author seq="3"><ce:initials>K.</ce:initials><ce:indexed-name>Lote K.</ce:indexed-name><ce:surname>Lote</ce:surname></author><author seq="4"><ce:initials>J.</ce:initials><ce:indexed-name>Norum J.</ce:indexed-name><ce:surname>Norum</ce:surname></author><author seq="5"><ce:initials>J.R.</ce:initials><ce:indexed-name>Henning J.R.</ce:indexed-name><ce:surname>Henning</ce:surname></author><author seq="6"><ce:initials>K.</ce:initials><ce:indexed-name>Tvera K.</ce:indexed-name><ce:surname>Tvera</ce:surname></author><author seq="7"><ce:initials>H.</ce:initials><ce:indexed-name>Hirschberg H.</ce:indexed-name><ce:surname>Hirschberg</ce:surname></author></ref-authors><ref-sourcetitle>Acta Neurchiurica</ref-sourcetitle><ref-publicationyear first="1999"/><ref-volisspag><voliss issue="2" volume="141"/><pagerange first="127" last="133"/></ref-volisspag></ref-info><ref-fulltext>Johannesen, T.B., Watne, K., Lote, K., Norum, J., Henning, J.R., Tvera, K., Hirschberg, H., Intracavity fractionated balloon brachytherapy in glioblastoma. Acta Neurchiurica 141:2 (1999), 127–133.</ref-fulltext><ce:source-text>Johannesen T.B., Watne K., Lote K., Norum J., Henning J.R., Tvera K. and Hirschberg H. Intracavity fractionated balloon brachytherapy in glioblastoma Acta Neurchiurica 141 (2) (1999) 127–133</ce:source-text></reference><reference id="30" reference-instance-id="OB2BibRecID-952395929-7a7d95597015df871398b333057a635d-30"><ref-info><ref-title><ref-titletext>ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single center phase III randomized controlled trial</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0030</itemid><itemid idtype="SGR">52949115237</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.S.</ce:initials><ce:indexed-name>Eljamel M.S.</ce:indexed-name><ce:surname>Eljamel</ce:surname></author><author seq="2"><ce:initials>C.</ce:initials><ce:indexed-name>Goodman C.</ce:indexed-name><ce:surname>Goodman</ce:surname></author><author seq="3"><ce:initials>H.</ce:initials><ce:indexed-name>Moseley H.</ce:indexed-name><ce:surname>Moseley</ce:surname></author></ref-authors><ref-sourcetitle>Lasers Med. Sci.</ref-sourcetitle><ref-publicationyear first="2008"/><ref-volisspag><voliss volume="23"/><pagerange first="361" last="367"/></ref-volisspag></ref-info><ref-fulltext>Eljamel, M.S., Goodman, C., Moseley, H., ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single center phase III randomized controlled trial. Lasers Med. Sci. 23 (2008), 361–367.</ref-fulltext><ce:source-text>Eljamel M.S., Goodman C., Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single center phase III randomized controlled trial. Lasers Med. Sci. 2008;23:361–367.</ce:source-text></reference><reference id="31" reference-instance-id="OB2BibRecID-952395929-4a82787d1b63a85da1e9e83d88c00cc3-31"><ref-info><ref-title><ref-titletext>Review of precision cancer medicine: evolution of the treatment paradigm</ref-titletext></ref-title><refd-itemidlist><itemid idtype="FRAGMENTID">bib0031</itemid><itemid idtype="ARTNUM">102019</itemid><itemid idtype="SGR">85082664741</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>A.M.</ce:initials><ce:indexed-name>Tsimberidou A.M.</ce:indexed-name><ce:surname>Tsimberidou</ce:surname></author><author seq="2"><ce:initials>E.</ce:initials><ce:indexed-name>Fountzilas E.</ce:indexed-name><ce:surname>Fountzilas</ce:surname></author><author seq="3"><ce:initials>M.</ce:initials><ce:indexed-name>Nikanjam M.</ce:indexed-name><ce:surname>Nikanjam</ce:surname></author><author seq="4"><ce:initials>R.</ce:initials><ce:indexed-name>Kurzrock R.</ce:indexed-name><ce:surname>Kurzrock</ce:surname></author></ref-authors><ref-sourcetitle>Cancer Treat. Rev.</ref-sourcetitle><ref-publicationyear first="2020"/><ref-volisspag><voliss volume="86"/></ref-volisspag><ref-text>Jun</ref-text></ref-info><ref-fulltext>Tsimberidou, A.M., Fountzilas, E., Nikanjam, M., Kurzrock, R., Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat. Rev., 86, 2020, 102019 Jun.</ref-fulltext><ce:source-text>Tsimberidou A.M., Fountzilas E., Nikanjam M., Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat. Rev. 2020 Jun;86:102019.</ce:source-text></reference></bibliography></tail></bibrecord></item></xocs:item></xocs:doc>